1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FBXO25 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA VWCE CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA CENPC CTRPv2 pan-cancer AAC 0.15 6e-05
mRNA RP11-426L16.10 CTRPv2 pan-cancer AAC -0.16 6e-05
mRNA CCSAP CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA VAMP3 CTRPv2 pan-cancer AAC -0.16 6e-05
mRNA SUPT16H CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA UNC119B CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA CNTD2 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA ZNF324 CTRPv2 pan-cancer AAC 0.14 6e-05
Download CSV